Patents by Inventor Tomohiro Nishimura
Tomohiro Nishimura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250244739Abstract: Means for achieving a new object which is reduction of jitter in position data which may be caused while a motor mechanically coupled to an encoder is stopped is provided. A control device includes an obtaining unit configured to obtain position data from an encoder, a smoothing unit configured to smooth the position data from the encoder, a state detector configured to detect an operating state of the motor mechanically coupled to the encoder, and an output unit configured to output the position data from the encoder every control cycle. The output unit is configured to output the position data from the encoder as it is while the motor is operating and to output the smoothed position data while the motor is stopped.Type: ApplicationFiled: October 21, 2022Publication date: July 31, 2025Applicant: OMRON CORPORATIONInventor: Tomohiro NISHIMURA
-
Publication number: 20250216886Abstract: A control device for controlling an actuator includes a storage that obtains a new distance command value at a first clock timing and stores the new distance command value as a latest value and an immediately preceding latest value as a previous value, a first calculator that calculates a distance inclination based on the latest and previous values and a number of second clocks within one cycle of the first clock, a second calculator that calculates a distance extrapolated value at a second clock timing, a first command generator that outputs a first command corresponding to a target distance when the distance extrapolated value reaches the target distance, and a clock controller that stops output of the second clock until a next cycle of the first clock when the number of the second clocks within one cycle of the first clock reaches a setting value.Type: ApplicationFiled: March 8, 2023Publication date: July 3, 2025Applicant: OMRON CORPORATIONInventor: Tomohiro NISHIMURA
-
Patent number: 12315771Abstract: A semiconductor module is provided, comprising a circuit board having a predetermined circuit pattern, a semiconductor chip placed on the circuit board, a wiring member configured to connect the semiconductor chip and the circuit pattern, and a sealing resin configured to seal the semiconductor chip and the wiring member, wherein the sealing resin has a first resin including an inorganic filler and an epoxy resin, which covers the semiconductor chip and a second resin having a smaller elastic modulus than the first resin, which is provided on a surface of the first resin, and wherein the second resin is separated from the semiconductor chip and the circuit board.Type: GrantFiled: August 24, 2021Date of Patent: May 27, 2025Assignee: FUJI ELECTRIC CO., LTD.Inventor: Tomohiro Nishimura
-
Patent number: 12290560Abstract: An object of the present invention is to provide an effective vaccine capable of preventing and treating congenital infection with CMV. The vaccine for preventing or treating congenital infection with cytomegalovirus (CMV) according to the present invention comprises a CMV envelope glycoprotein B (gB protein) antigen and a pentamer antigen.Type: GrantFiled: December 6, 2019Date of Patent: May 6, 2025Assignee: KM Biologics Co., Ltd.Inventors: Masaharu Torikai, Hiroaki Mori, Tomohiro Nishimura, Takahiro Katayama, Kohsuke Hazeyama, Miyuki Matsumoto, Hiroyuki Shimizu, Naoki Inoue
-
Patent number: 12220457Abstract: The present invention is directed to provide a modified CMV gB protein that can induce a group of antibodies including a high ratio of neutralizing antibodies that exhibit a high neutralizing activity against a CMV gB protein, in comparison with a wild type CMV gB, upon induction of immunity and that can be used in the prevention and/or treatment of CMV infection and a CMV vaccine comprising the modified CMV gB protein. The modified CMV gB protein according to the present invention is a modified CMV gB protein having an improved ability to induce body region-recognizing antibodies and comprising modification in a head region.Type: GrantFiled: October 24, 2019Date of Patent: February 11, 2025Assignee: KM Biologics Co., Ltd.Inventors: Masaharu Torikai, Hiroaki Mori, Tomohiro Nishimura, Miyuki Matsumoto, Hiroyuki Shimizu, Akihiro Koube, Takamasa Nagatomo, Naoki Inoue
-
Patent number: 11887941Abstract: Provided is a semiconductor module, including: a semiconductor chip; a circuit board on which the semiconductor chip is mounted; a sealing resin including epoxy resin for sealing the semiconductor chip and the circuit board; and a reinforcing material, with a higher Young's modulus than the sealing resin, provided in close contact with the sealing resin above at least a part of the sealing resin. The semiconductor module includes a resin case for enclosing spaces for housing the semiconductor chip, wherein the sealing resin may be provided inside the resin case.Type: GrantFiled: August 24, 2021Date of Patent: January 30, 2024Assignee: FUJI ELECTRIC CO., LTD.Inventor: Tomohiro Nishimura
-
Patent number: 11840096Abstract: A semiconductor device is adapted for controlling energization of a heating element that performs printing. The semiconductor device includes: a strobe signal input unit receiving a printing strobe signal that causes the heating element to generate heat for printing; a preheating strobe generation circuit generating a preheating strobe signal that causes the heating element to preheat by compressing a waveform of the printing strobe signal in a time axis direction; and an output controller outputting a control signal that controls energization of the heating element based on the printing strobe signal and the preheating strobe signal.Type: GrantFiled: April 15, 2021Date of Patent: December 12, 2023Assignees: SEIKO EPSON CORPORATION, ROHM Co., Ltd.Inventors: Hiroki Wachi, Koji Nishi, Tomohiro Nishimura
-
Publication number: 20220410313Abstract: An interpolation parameter calculation unit calculates an interpolation parameter of a predetermined interpolation calculation formula based on a first plurality of coordinate values input by means of a coordinate input unit and constituting a coordinate pattern for determining a locus pattern of one cycle when a laser beam is vibrated. A locus pattern calculation unit calculates a second plurality of coordinate values constituting the locus pattern based on an interpolation parameter, respective amplitudes of the locus pattern in an x-axis direction that is a moving direction of a processing head and a y-axis direction that is a direction orthogonal to the x-axis direction, a frequency of the locus pattern, and a control cycle of a beam vibration mechanism for vibrating the laser beam.Type: ApplicationFiled: November 30, 2020Publication date: December 29, 2022Inventors: Chiaki KAWAHARA, Tomohiro NISHIMURA, Shin IRIE
-
Patent number: 11472867Abstract: An anti-HSV monoclonal antibody or an antigen-binding fragment thereof is an anti-HSV gB monoclonal antibody or an antigen-binding fragment thereof that specifically binds to herpes simplex virus (HSV) envelope glycoprotein B (gB), comprising: a heavy chain variable region comprising a heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 3, a heavy chain CDR2 consisting of the amino acid sequence set forth in SEQ ID NO: 4, and a heavy chain CDR3 consisting of the amino acid sequence set forth in SEQ ID NO: 5; and a light chain variable region comprising a light chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 6, a light chain CDR2 consisting of the amino acid sequence set forth in SEQ ID NO: 7, and a light chain CDR3 consisting of the amino acid sequence set forth in SEQ ID NO: 8.Type: GrantFiled: August 29, 2018Date of Patent: October 18, 2022Assignee: KM BIOLOGICS CO., LTD.Inventors: Hiroaki Mori, Tomohiro Nishimura, Hiroyuki Shimizu, Akihiro Koube
-
Patent number: 11421002Abstract: A modified protein of a herpes simplex virus (HSV) envelope glycoprotein B (gB), in which at least one non-neutralizing antibody-inducing epitope (non-neutralizing epitope) present in domain IV and domain I of wild-type HSV gB is inactivated (de-epitoped).Type: GrantFiled: August 29, 2018Date of Patent: August 23, 2022Assignee: KM BIOLOGICS CO., LTD.Inventors: Hiroaki Mori, Tomohiro Nishimura, Hiroyuki Shimizu, Miyuki Matsumoto
-
Publication number: 20220250141Abstract: The objective of the present invention is to improve non-defective product yield by reducing shrinkage cavities inside small-diameter ingots, in a method for casting active metals. In this Ti—Al based alloy casting method for casting an ingot of Ti—Al based alloy by tapping molten metal from a tapping hole (5) provided in a bottom portion of a water-cooled copper crucible (2), in an induction melting furnace (3) employing said crucible (2), into a casting mold (4), the degree of vacuum inside the induction melting furnace (3) when the Ti—Al based alloy is being melted or cast is in a range of 80 to 700 Torr, and the Al concentration in the cast ingot is within ±1.0 mass % of a target value.Type: ApplicationFiled: July 10, 2020Publication date: August 11, 2022Applicant: Kabushiki Kaisha Kobe Seiko Sho (Kobe Steel, Ltd.)Inventors: Tomohiro NISHIMURA, Daisuke MATSUWAKA, Hitoshi ISHIDA
-
Patent number: 11357847Abstract: The modified HSV gD protein of the present invention is a modified protein of a herpes simplex virus (HSV) envelope glycoprotein D (gD), wherein the modified HSV gD protein is derived from a wild-type HSV gD by modification of at least one of B cell epitopes having low or no neutralizing antibody-inducing activity compared to a B cell epitope present in a receptor-binding domain (RBD) (decotopes) in the ectodomain of the wild-type HSV gD, so that the modified epitope does not function as an epitope.Type: GrantFiled: August 29, 2018Date of Patent: June 14, 2022Assignee: KM BIOLOGICS CO., LTD.Inventors: Hiroaki Mori, Tomohiro Nishimura, Hiroyuki Shimizu, Akihiro Koube, Takahiro Katayama
-
Publication number: 20220115284Abstract: A semiconductor module is provided, comprising a circuit board having a predetermined circuit pattern, a semiconductor chip placed on the circuit board, a wiring member configured to connect the semiconductor chip and the circuit pattern, and a sealing resin configured to seal the semiconductor chip and the wiring member, wherein the sealing resin has a first resin including an inorganic filler and an epoxy resin, which covers the semiconductor chip and a second resin having a smaller elastic modulus than the first resin, which is provided on a surface of the first resin, and wherein the second resin is separated from the semiconductor chip and the circuit board.Type: ApplicationFiled: August 24, 2021Publication date: April 14, 2022Inventor: Tomohiro NISHIMURA
-
Publication number: 20220108959Abstract: Provided is a semiconductor module, including: a semiconductor chip; a circuit board on which the semiconductor chip is mounted; a sealing resin including epoxy resin for sealing the semiconductor chip and the circuit board; and a reinforcing material, with a higher Young's modulus than the sealing resin, provided in close contact with the sealing resin above at least a part of the sealing resin. The semiconductor module includes a resin case for enclosing spaces for housing the semiconductor chip, wherein the sealing resin may be provided inside the resin case.Type: ApplicationFiled: August 24, 2021Publication date: April 7, 2022Inventor: Tomohiro NISHIMURA
-
Publication number: 20220023416Abstract: An object of the present invention is to provide an effective vaccine capable of preventing and treating congenital infection with CMV. The vaccine for preventing or treating congenital infection with cytomegalovirus (CMV) according to the present invention comprises a CMV envelope glycoprotein B (gB protein) antigen and a pentamer antigen.Type: ApplicationFiled: December 6, 2019Publication date: January 27, 2022Inventors: Masaharu TORIKAI, Hiroaki MORI, Tomohiro NISHIMURA, Takahiro KATAYAMA, Kohsuke HAZEYAMA, Miyuki MATSUMOTO, Hiroyuki SHIMIZU, Naoki INOUE
-
Publication number: 20210346494Abstract: The present invention is directed to provide a modified CMV gB protein that can induce a group of antibodies including a high ratio of neutralizing antibodies that exhibit a high neutralizing activity against a CMV gB protein, in comparison with a wild type CMV gB, upon induction of immunity and that can be used in the prevention and/or treatment of CMV infection and a CMV vaccine comprising the modified CMV gB protein. The modified CMV gB protein according to the present invention is a modified CMV gB protein having an improved ability to induce body region-recognizing antibodies and comprising modification in a head region.Type: ApplicationFiled: October 24, 2019Publication date: November 11, 2021Inventors: Masaharu TORIKAI, Hiroaki MORI, Tomohiro NISHIMURA, Miyuki MATSUMOTO, Hiroyuki SHIMIZU, Akihiro KOUBE, Takamasa NAGATOMO, Naoki INOUE
-
Publication number: 20210323316Abstract: A semiconductor device is adapted for controlling energization of a heating element that performs printing. The semiconductor device includes: a strobe signal input unit receiving a printing strobe signal that causes the heating element to generate heat for printing; a preheating strobe generation circuit generating a preheating strobe signal that causes the heating element to preheat by compressing a waveform of the printing strobe signal in a time axis direction; and an output controller outputting a control signal that controls energization of the heating element based on the printing strobe signal and the preheating strobe signal.Type: ApplicationFiled: April 15, 2021Publication date: October 21, 2021Applicants: SEIKO EPSON CORPORATION, ROHM Co., Ltd.Inventors: Hiroki WACHI, Koji NISHI, Tomohiro NISHIMURA
-
Publication number: 20210205441Abstract: The modified HSV gD protein of the present invention is a modified protein of a herpes simplex virus (HSV) envelope glycoprotein D (gD), wherein the modified HSV gD protein is derived from a wild-type HSV gD by modification of at least one of B cell epitopes having low or no neutralizing antibody-inducing activity compared to a B cell epitope present in a receptor-binding domain (RBD) (decotopes) in the ectodomain of the wild-type HSV gD, so that the modified epitope does not function as an epitope.Type: ApplicationFiled: August 29, 2018Publication date: July 8, 2021Inventors: Hiroaki MORI, Tomohiro NISHIMURA, Hiroyuki SHIMIZU, Akihiro KOUBE, Takahiro KATAYAMA
-
Publication number: 20200299334Abstract: A modified protein of a herpes simplex virus (HSV) envelope glycoprotein B (gB), in which at least one non-neutralizing antibody-inducing epitope (non-neutralizing epitope) present in domain IV and domain I of wild-type HSV gB is inactivated (de-epitoped).Type: ApplicationFiled: August 29, 2018Publication date: September 24, 2020Inventors: Hiroaki MORI, Tomohiro NISHIMURA, Hiroyuki SHIMIZU, Miyuki MATSUMOTO
-
Publication number: 20200302661Abstract: An information processing apparatus includes: a memory; and a processor coupled to the memory and configured to: receive input of two pieces of data, one of the two pieces of data being data for indicating a procedure of a combination of a plurality of drawings; generate virtual drawing data based on the data for indicating the procedure; and output a comparison result between the virtual drawing data that is generated and another comparison data of the two pieces of data.Type: ApplicationFiled: March 16, 2020Publication date: September 24, 2020Applicant: FUJITSU LIMITEDInventors: Toshiya YAMAZAKI, Tomohiro Nishimura